In a significant/important/landmark development for the treatment of spinal muscular atrophy (SMA), the Delhi High Court has upheld/approved/supported the regulatory approval/permission/sanction for the drug risdiplam https://adamyiwf406888.blog-gold.com/50973564/the-delhi-high-court-agrees-to-regulatory-approval-for-risdiplam-in-india